Management of respiratory syncytial virus infections in the immunocompromised child

Pediatr Infect Dis J. 2000 Mar;19(3):253-4. doi: 10.1097/00006454-200003000-00017.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Child
  • Humans
  • Immunocompromised Host*
  • Infant
  • Respiratory Syncytial Virus Infections / diagnosis
  • Respiratory Syncytial Virus Infections / prevention & control
  • Respiratory Syncytial Virus Infections / therapy*
  • Respiratory Syncytial Viruses*
  • Ribavirin / therapeutic use*
  • Risk Factors
  • Viral Vaccines

Substances

  • Antiviral Agents
  • Viral Vaccines
  • Ribavirin